Company News
GNI Group Acquires Ayumi Pharmaceutical for ¥44.8bn
GNI Group announced acquisition of Ayumi Pharmaceutical for ¥44.8 billion, making Ayumi a wholly‑owned subsidiary.
Post‑announcement, GNI’s shares rose 11% in a week, with market cap now $986 million.
